These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6833768)

  • 1. Stripping of endogenous ligands from antisera against glucagon.
    Grønholt R; Holst JJ
    J Immunol Methods; 1983 Mar; 58(1-2):83-91. PubMed ID: 6833768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of antiglucagon antibodies in rabbits and guinea pigs using a glucagon-carbodiimide-albumin conjugate.
    Flatt PR; Swanston-Flatt SK
    Endocrinol Exp; 1981; 15(1):3-16. PubMed ID: 6971218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High titer glucagon antisera.
    Tager HS; Hohenboken M; Markese J
    Endocrinology; 1977 Feb; 100(2):367-72. PubMed ID: 832629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radioligand assay: method and application. II. Effect of glucagon coupling on the production of glucagon antisera with suitable binding parameters for radioimmunoassay].
    Ziegler M; Keilacker H; Woltanski KP; Besch W; Schubert J
    Acta Biol Med Ger; 1980; 39(2-3):305-14. PubMed ID: 6775484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of anti-glucagon sera with a C-terminal fragment of pancreatic glucagon.
    Imagawa K; Nishino T; Shin S; Uehata S; Hashimura E; Yanaihara C; Yanaihara N
    Endocrinol Jpn; 1979 Feb; 26(1):123-31. PubMed ID: 86440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of endogenous ligands from a high-affinity antiserum for radioimmunoassay.
    Kruse V
    Scand J Clin Lab Invest; 1979 Oct; 39(6):533-41. PubMed ID: 43579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a specific antiserum by synthetic C-terminal fragment of glucagon.
    Ohneda A; Watanabe K; Wakimatsu M; Fujino M
    Horm Metab Res; 1979 Aug; 11(8):463-8. PubMed ID: 574120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of glucagon by antiserum as a tool in glucagon physiology. Lack of depression of basal blood glucose after antiserum treatment in rats.
    Holst JJ; Galbo H; Richter EA
    J Clin Invest; 1978 Jul; 62(1):182-90. PubMed ID: 659632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of an antiserum against pancreatic glucagon.
    Von Schenck H
    Clin Chim Acta; 1977 Nov; 80(3):455-63. PubMed ID: 912916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation rate constants and fractional binding of tracer estimated for three antibody populations in unstripped and stripped antiserum.
    Kruse V
    Scand J Clin Lab Invest; 1979 May; 39(3):215-21. PubMed ID: 523970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
    Blache P; Kervran A; Martinez J; Bataille D
    Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.
    Edwards RJ; Singleton AM; Murray BP; Davies DS; Boobis AR
    Biochem Pharmacol; 1995 Jan; 49(1):39-47. PubMed ID: 7840781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and evaluation of antibodies for radioimmunoassay of secretin.
    Fahrenkrug J; Muckadell OB; Rehfeld JF
    Scand J Clin Lab Invest; 1976 May; 36(3):281-7. PubMed ID: 940982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly specific antisera against native ovine follitropin (oFSH) obtained from crude antisera by affinity chromatography on solid-phase undissociable lutropin (LH) column.
    Poirier JC; Combarnous Y; Blanc MR
    Acta Endocrinol (Copenh); 1984 May; 106(1):38-42. PubMed ID: 6428115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modification of the unlabeled antibody enzyme method using heterologous antisera for the light microscopic and ultrastructural localization of insulin, glucagon and growth hormone.
    Erlandsen SL; Parsons JA; Burke JP; Redick JA; Van Orden DE; Van Orden LS
    J Histochem Cytochem; 1975 Sep; 23(9):666-77. PubMed ID: 1176760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of N-terminally and C-terminally directed monoclonal antibodies against pancreatic glucagon.
    Gregor M; Riecken EO
    Gastroenterology; 1985 Sep; 89(3):571-80. PubMed ID: 3839481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of antisera for cortisol immunoassay by reduction of endogenous hormone concentrations.
    Hindawi RK; Read GF; Riad-Fahmy D
    J Immunol Methods; 1980; 37(1):57-70. PubMed ID: 7430661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the alpha 1- and alpha 2-selective antagonists prazosin and yohimbine as probes of the alpha-adrenergic binding sites.
    Graham RM; Hess HJ; Haber E; Homcy CJ
    Hypertension; 1982; 4(3 Pt 2):183-7. PubMed ID: 6279501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-α-galactoside and Anti-β-glucoside Antibodies are Partially Occupied by Either of Two Albumin-bound O-glycoproteins and Circulate as Ligand-binding Triplets.
    Sreedevi K; Subramanian SP; Mandagini G; Appukuttan PS
    Immunol Invest; 2019 Apr; 48(3):222-241. PubMed ID: 30081721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.